FOLLICULAR LYMPHOMA
Clinical trials for FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune-boosting drug tested in untreated lymphoma patients
Disease control TerminatedThis study tested the drug pembrolizumab in 9 people with untreated B-cell non-Hodgkin lymphoma. The goal was to see if the drug helps the immune system shrink or control the cancer. The trial was stopped early, so results are limited.
Matched conditions: FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 17, 2026 08:00 UTC
-
Experimental combo for tough lymphoma shows early promise
Disease control TerminatedThis early-stage trial tested a combination of two drugs, tazemetostat and venetoclax, in people with Non-Hodgkin lymphoma that had returned or stopped responding to standard treatments. The main goals were to find the safest dose of venetoclax to use with tazemetostat and to see…
Matched conditions: FOLLICULAR LYMPHOMA
Phase: PHASE1 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Lymphoma drug combo shows promise in early trial
Disease control TerminatedThis study tested a combination of two drugs, umbralisib and rituximab, as the first treatment for people with follicular lymphoma or marginal zone lymphoma. The goal was to see how many patients had their cancer completely disappear. The study was stopped early and included 18 a…
Matched conditions: FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Apr 24, 2026 16:19 UTC